Language: 简体中文 English
Your location: Home > Program
Query:
Date:
  • All
  • November 19, 2026
  • November 20, 2026
  • November 21, 2026
Hall:
  • All
  • 5th‑Floor Grand Ballroom
  • S101
  • S102
  • S103
  • S105
  • S106
  • S107
  • S109
  • S110
  • S111
  • S201
  • S202
  • S203
  • S204
  • S205
  • S206
  • S207
  • V11
  • V22
  • V23
  • V24
  • V25
  • InterContinental Ballroom 1
Subject:
  • All
  • Plenary Session
  • Oncology
  • Minimally Invasive Surgery
  • Stones
  • Incontinence
  • Robotic Surgery
  • Clinical Research
  • Basic and Translational Science
  • Female Urology
  • Andrology
  • Nursing
  • Infection
  • Renal Transplantation
  • Laser Surgery
  • Community Urology
  • Reconstructive Surgery
  • Adrenals
  • Pediatric Urology
  • Smart Surgery
  • Urological Engineering
  • Special Session
  • Prostate Cancer Pathfinders: Evidence into Action
  • Prostate Neoplasms Session
  • Benign Diseases Diagnosis & Treatment Session
  • Urolithiasis Standardized Care Project
  • Discovering Urological Frontiers
  • Urology & Prostate
  • Rising Leaders Urology
  • Urologic Oncology Session
  • Training Program for Urological Department
  • Precision Care in Urologic Oncology
  • Uro-Oncology Leadership & Innovation Forum
  • Remote Session: Normalized Surgical Practice
  • RCC Immunotherapy Session
  • Intelligent Leadership in Prostate Care
  • Bladder Cancer Session
  • MP + SP in URO Seminar
  • Benign Prostatic Hyperplasia Session
  • Ingenuity Exploration
  • Renal Cell Carcinoma Session
  • Prostate Cancer Session

November 21, 2026

S201

November 21, 2026 08:00-08:20 Opening Remarks Basic and Translational Science
Moderator :
1 08:00-08:10

Opening Remarks

Xu Zhang China
. China
November 21, 2026 08:20-09:40 Session 1 Oral Presentations 1 Basic and Translational Science
1 08:20-08:30

Genetics in prostate cancer: from hereditary risk to precision medicine

Avelino Fraga Portugal
2 08:30-08:40

All Roads Lead to AR: The Androgen Receptor in Modern Prostate Cancer Care

Jun Luo United States
3 08:40-08:50

Immunosuppressive and Prognostic Significance of MS4A4A-Positive Macrophages in Bladder Cancer

Bo Wang China
4 08:50-09:00

Single-Cell and Spatial Transcriptomics Reveal Metastatic Subtyping and Molecular Mechanisms of Pheochromocytoma

Zechen Yan China
5 09:00-09:10

The VGF-MYH9-GSK3β-Wnt/β-Catenin Axis Promotes Prostate Cancer Progression by Reprogramming Glycolysis and the Immune Microenvironment

Tao Tao China
6 09:10-09:20

A clinically translatable super-inert near-infrared fluorescent dye for surgical navigation

Haoran Liu China
7 09:20-09:30

Advancing Clinical Research in Diabetic Kidney Disease: Experience from the DYNAMO Study

Thomas M.Coffman Singapore
8 09:30-09:40

Clinical Big Data and Artificial Intelligence-Based Integrated Diagnosis and Treatment for Prostate Cancer

Fubo Wang China
November 21, 2026 09:40-11:00 Session 2 Oral Presentations2 Basic and Translational Science
1 09:40-09:50

AR-degrading peptide, a novel solution for prostate cancer

Benyi Li United States
2 09:50-10:00

SIRT5-Mediated Desuccinylation of FASN Regulates Lipid Metabolic Reprogramming and Promotes Prostate Cancer Cell Proliferation

Boyu Yang China
3 10:00-10:10

The DIS3–glycoRNA Axis Drives Early Tumor Immune Evasion by Remodeling DC–T Cell Immune Responses

Xin Liu China
4 10:10-10:20

VHL inhibits autophagy and tumor development by modulating ATG14 hydroxylation in a PHD1-dependent manner

Chuandong Wang China
5 10:20-10:30

SLC26A7+ Cancer-Associated Fibroblasts Promote Axitinib Resistance in Renal Cell Carcinoma via TET1 Lactylation Modification

Yihui Pan China
6 10:30-10:40

Cytoskeletal Protein KRT14 Governs Cisplatin Resistance by Modulating eIF4H-Dependent ACOX2 Translation and Lipid Metabolism in Bladder Cancer

Shenghua Liu China
7 10:40-10:50

A Novel Natural Tumor-Suppressive Micropeptide Removes the TRIM25-Mediated Anti-Ferroptosis Barrier and Inhibits Bladder Cancer Progression

Weijian Li China
8 10:50-11:00

Environmental Pollutant DEHP Drives Castration-Resistant Prostate Cancer Progression via OTUB2-Mediated Deubiquitination of MDM2

Fei Lin China
November 21, 2026 11:00-12:20 Session 3 Oral Presentations 3 Basic and Translational Science
1 11:00-11:10

tbd China
2 11:10-11:20

TE-RPA: A Single-Tube Telomerase Extension-Recombinase Polymerase Amplification-Based Electrochemical Biosensor for Precise Diagnosis of Urothelial Carcinoma

Hongxing Liu China
3 11:20-11:30

Integrative spatial dissection of tumor microenvironment architecture in bladder cancer invasion

Zongzheng Yang China
4 11:30-11:40

Epigenomic Analysis Reveals AR-Associated Enhancer RNAs Modulate LTF Transcription to Influence Ferroptosis in Prostate Cancer

Cheng Ma China
5 11:50-12:00

Exosomal ST6GAL1 from Prostate Cancer Promotes Perineural Invasion by Regulating Neuronal NGF Secretion via the Integrin β1/FAK/ERK Signaling Axis

Yunfeng Zhang China
6 11:50-12:00

LncCAM6A Promotes Sunitinib Resistance in Renal Cell Carcinoma by Activating Pyrimidine Synthesis via RBM15-Mediated m6A Modification of NAGS

Haibo Zhang China
7 12:00-12:10

Single-Cell Glyco-LacNAc Multi-Omics-Based Development of a Draining Lymph Node-Derived T Cell Therapy for Bladder Cancer

Xiangyu Wu China
8 12:10-12:20

The Non-Canonical Function of Claudin-1 Drives Prostate Cancer Lineage Plasticity and Chemotherapy Resistance by Alleviating Lethal Endoplasmic Reticulum Stress

Youjian Li China
November 21, 2026 13:30-13:40 Opening Remarks Basic and Translational Science
1 13:30-13:40

Opening Remarks

. China
November 21, 2026 13:40-15:00 Session 1 Oral Presentations 4 Basic and Translational Science
1 13:40-13:50

Fasting-Mimicking Diet-Driven Taurocholic Acid Reduction Enhances Renal Cell Carcinoma Immunotherapy by Attenuating MDSC-Mediated Immunosuppression

Xin Qin China
2 13:50-14:00

Gut Microbiota Dysbiosis After Androgen Deprivation Promotes Castration-Resistant Prostate Cancer Progression via TMAO-Mediated Remodeling of SPP1⁺ Tumor-Associated Macrophages

Bisheng Cheng China
3 14:10-14:20

Single-Cell Spatial Atlas Reveals Prostate Cancer Immune Microenvironment Heterogeneity and Identifies CCL18⁺ Macrophages as a Predictive Biomarker for Immunotherapy Response

Zhicheng Zheng China
4 14:20-14:30

Wearable Low-Intensity Ultrasound Drives Fibroblasts Toward an FGF10⁺ Phenotype to Promote Postoperative Urethral Remodeling

Mingming Yu China
5 14:30-14:40

Exploring the Interrelationship Among Metabolic Syndrome, IGF-1, and Benign Prostatic Hyperplasia in a Sprague-Dawley Rat Model

Sicong Zhao China
6 14:40-14:50

Environmental Endocrine-Disrupting Chemical Exposure Promotes Prostate Cancer Progression by Regulating the Tumor Immune Microenvironment

Yuming Jin China
7 14:50-15:00

Integrated CosMx Spatial Transcriptomics and FFPE Single-Nucleus RNA Sequencing Reveal Perineural Invasion-Associated Tumor Subpopulations and Castration-Resistant Features in Prostate Cancer

Lei Tang China
8 15:00-15:10

Break

November 21, 2026 15:10-16:35 Session 2 Oral Presentations 5 Basic and Translational Science
1 15:10-15:20

Exercise Alleviates Benign Prostatic Hyperplasia via Synergistic Serotonylation and Lactylation

Jiaming Wang China
2 15:20-15:30

Cytoplasmic Translocation of SIRT5 Remodels Glycolytic Metabolic Flux to Promote Castration-Resistant Prostate Cancer: Mechanisms and Therapeutic Strategies

Duo Kan China
3 15:30-15:40

Multi-Omics Integration Reveals ZDHHC24 Drives Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Regulating Lipid Metabolism

Wei Li China
4 15:40-15:50

YWHAG Promotes Bladder Cancer Progression by Competitively Inhibiting FBXL7-Mediated Ubiquitination of BCLAF1

Yuzhen Jie China
5 15:50-16:00

HE Slide-Based Spatial Gene Expression Prediction Model Deciphers Spatial Transcriptomic Features and Clinical Significance in Bladder Cancer

Wenwei Ying China
6 16:00-16:10

Lactylation Atlas of Clear Cell Renal Cell Carcinoma Reveals Ferritin Lactylation Regulates Ferroptosis by Inhibiting Ubiquitin-Proteasome Degradation

Jiali Ye China
7 16:10-16:20

Single-Cell Sequencing Reveals SERPINE1⁺ Tumor Cells Remodel a Treg-Enriched Microenvironment via the JAK2/STAT3/TGF-β Axis to Drive Neoadjuvant Immunotherapy Resistance in Renal Cell Carcinoma

Cheng Peng China
November 21, 2026 16:40-18:00 Session 3 Oral Presentations 6 Basic and Translational Science
1 16:40-16:50

UBTF Remodels the Androgen Receptor Chromatin Binding Landscape and Activates DNA Damage Repair Programs to Promote Prostate Cancer Progression

Nengyuan Li China
2 16:50-17:00

GATAD1 Downregulation in Adrenal DLPC Promotes Ectopic Calcification of Arteries and Renal Interstitium

Yizhou Wang China
3 17:00-17:10

YTHDF3 Facilitates Cytoskeletal Remodeling to Promote Mitochondrial Transfer and CD8⁺ T Cell Exhaustion in Prostate Cancer

Xiaoyang Li China
4 17:10-17:20

Mechanotransduction-Translation Coupling Mediates Cavernous Fibroblast Phenotypic Switching: A New Perspective on Diabetic Erectile Dysfunction Pathogenesis

Liangyu Zhao China
5 17:20-17:30

Application Value of ADAM19 in CTC EMT Subtyping and Prognostic Assessment for Renal Cell Carcinoma

Minxin He China
6 17:30-17:40

Targeting AREG⁺ Dendritic Cells Alleviates Renal Fibrosis Induced by Ischemia-Reperfusion Injury

Xin Luo China
7 17:40-17:50

Therapeutic Effect and Preliminary Mechanisms of FAST Whole-Cell Tumor Vaccine Combined with SBRT in Renal Cell Carcinoma

Gang Chen China
8 17:50-18:00

Identification of CD276 Ligands and Receptors and Exploration of Their Biological Functions in Urological Tumors

Lilong Liu China
November 21, 2026 18:00-18:10 Summary Basic and Translational Science
Moderator :
1 18:00-18:10

Summary

. China